CompletedNot Applicable

COVID-19 Vaccination AZV 2021-2023

Czechia3,000 participantsStarted 2021-01-01

Plain-language summary

The study is aimed at the clinical and laboratory characteristics of patients with completed vaccination against SARS-CoV-2 admitted to the hospital in the standard ward and intensive care unit due to the severe course of COVID-19.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients * COVID-19 positiveness * vaccination against SARS-CoV-2 (any number of doses) Exclusion Criteria: * N/A

What they're measuring

Patient phenotype

Timeframe: 1.1.2021 - 30.6.2023

Trial details

NCT IDNCT05589233

SponsorUniversity Hospital Hradec Kralove

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11-30

View on ClinicalTrials.gov More COVID-19 trials